Irena is the Vice President of Finance at aMoon and has over 12 years of finance management experience in public companies and business units of global enterprises.
Prior to joining aMoon, Irena was the VP Finance of Alcobra (NASDAQ: ADHD) a development-stage biotech company where she led the financial aspects of Alcobra’s operations and has played a key role in Public equity offering and Alcobra’s merger with Arcturus Therapeutics (NASDAQ: ARCT), a San-Diego based mRNA company.
Prior to joining Alcobra, she was Finance Manager at Omrix Biopharmaceuticals, a Johnson &Johnson company.
Irena began her career as a Senior Associate in the high-tech cluster at PwC Israel.
Irena is a Certified Public Accountant and holds a B.A. in Economics and Accounting from the Hebrew University of Jerusalem and an M.B.A. from Tel Aviv University.